|
Post by realisticview on Apr 7, 2014 17:21:17 GMT -5
Is it bothersome that the panel viewed Afrezza as being beneficial for only a small percentage of diabetics and that they viewed it as not as effective as injected insulin? I'd appreciate it it if I was not identified as a basher or a short or had my account disabled. I'm actually long but am very concerned by the 3 month delay. 3 months? Really? I could see a month to hash out the label and any post approval studies. After all, how many years have they had this (Afrezza) in front of them.
I don't for a second believe the last CRL was related to dipwad's Christmas letter to the FDA, but I'm very suspicious that the FDA was looking to decline Afrezza this time before the AdCom panel voted thumbs up.
Regards,
Tom Thumb.
|
|
|
Post by liane on Apr 7, 2014 17:37:40 GMT -5
realisticview,
There's nothing in the substance of your post that would cause your account to be disabled. We're willing to discuss any view that is well presented and respectful.
I do want to point out though that you appear to have multiple IDs (herman, piccolopete, and proctologistpete) as evidenced by IP address.
Please send me a PM explaining this or I will be forced to disable the extraneous accounts. Thank you.
|
|
|
Post by babaoriley on Apr 7, 2014 18:41:11 GMT -5
"I do want to point out though that you appear to have multiple IDs (herman, piccolopete, and proctologistpete) as evidenced by IP address."
So coldly efficient, Liane!
|
|